Articles

Co-occurrence of cohesin complex and Ras signaling mutations during progression from myelodysplastic syndromes to secondary acute myeloid leukemia

Institute of Biomedical Research of Salamanca, Cancer Research Center-University of Salamanca, Spain;
Institute of Biomedical Research of Salamanca, Cancer Research Center-University of Salamanca, Spain;
Institute of Biomedical Research of Salamanca, Cancer Research Center-University of Salamanca, Spain;
Hospital del Mar Medical Research Institute (IMIM), Barcelona and Karolinska Institutet, Stockholm.;
University of Salamanca, IBSAL, Hematology, Hospital Clinico Universitario, Salamanca, Spain;
Hematology, Hospital Universitario de León, Institute of Biomedicine (IBIOMED), Spain;
Institute of Biomedical Research of Salamanca, Cancer Research Center-University of Salamanca, Spain;
Hematology, Hospital Universitario Miguel Servet, Zaragoza, Spain.;
Hematology, Hospital del Bierzo, Ponferrada, León, Spain.;
Hematology, Hospital Universitario de Burgos, Burgos, Spain.;
Hematology, Hospital Universitario de León, Institute of Biomedicine (IBIOMED), Spain;
Hematology, Hospital General de Segovia, Segovia, Spain.;
Hematology, Hospital Nuestra Señora de Sónsoles, Ávila, Spain.;
Hematology, Hospital Santa Bárbara, Soria, Spain.;
Hematology, Hospital Juan Ramón Jiménez, Huelva, Spain.;
Hematology, Hospital Virgen del Puerto, Plasencia, Spain.;
Institute of Biomedical Research of Salamanca, Cancer Research Center-University of Salamanca, Spain;
Institute of Biomedical Research of Salamanca, Cancer Research Center-University of Salamanca, Spain;
Institute of Biomedical Research of Salamanca, Cancer Research Center-University of Salamanca, Spain;
University of Salamanca, IBSAL, Hematology, Hospital Clínico Universitario, Salamanca, Spain
Institute of Biomedical Research of Salamanca, Cancer Research Center-University of Salamanca, Spain;
Haematologica Early view Jul 16, 2020 https://doi.org/10.3324/haematol.2020.248807